Peer-reviewedCC BYFrontiers in genome editing
Gene therapy for non-obstructive azoospermia: therapeutic avenues and translational pathway to clinical application
- 1Center for Reproductive Medicine, The Affiliated Guangdong Second Provincial General Hospital of Jinan University , ,
- 2New York Fertility Center, New York-Prebyterian Healthcare System Affiliate Weill Cornell Medical College , , ,
- 3Department of Immunology, University of Pittsburgh , , ,
Related
- AAV9 Gene Therapy for Ovarian Dysfunction and Reproductive Aging: Molecular Mechanisms, Therapeutic Targets, and Translational Perspectives
- Sulforaphane as a Therapeutic Target for Sarcopenia in Type 2 Diabetes: Mechanistic Insights and Translational Evidence.
- Enzyme-Immobilized Nanomaterials for Endocrine Disorders: Therapeutic Innovation and Translational Challenges.
- The dual role of small EVs in asthma and chronic obstructive pulmonary disease: from pathogenesis to clinical translation
- Clinical translational research on stem cell products: prospects and challenges
BibTeX
@article{jiang2026gene,
title = {{Gene therapy for non-obstructive azoospermia: therapeutic avenues and translational pathway to clinical application}},
author = {Man-Xi Jiang and Tao Jing and Huai L. Feng and Yan Zhu},
journal = {Frontiers in genome editing},
year = {2026},
month = oct,
url = {https://europepmc.org/article/PMC/PMC13662417},
note = {CC BY},
}
RIS
TY - JOUR
TI - Gene therapy for non-obstructive azoospermia: therapeutic avenues and translational pathway to clinical application
AU - Man-Xi Jiang
AU - Tao Jing
AU - Huai L. Feng
AU - Yan Zhu
PY - 2026
DA - 2026/10/16
JO - Frontiers in genome editing
UR - https://europepmc.org/article/PMC/PMC13662417
SN - 2673-3439
ER -